Earnings Releases·Nov 4, 2026, 4:07 PM ET

agilon health — Third Quarter 2026 Earnings Summary

Total revenue grew 6% year-over-year to $1.52 billion, while net income turned positive at $35 million, reversing a $110 million loss in Q3 2025; Adjusted EBITDA improved to $64 million from a $91 million loss.
Full-year 2026 guidance was raised across key metrics: revenue to $5.87–$5.89 billion, Adjusted EBITDA to $145–$155 million, and MSER to 90.3–90.5%.
Membership declined to 566,000 as the company executed a disciplined contracting strategy and market exits, though revenue growth was driven by higher illness burden, improved pricing, and favorable claims development.
The company maintains a strong liquidity position with $312 million in cash and marketable securities against $32 million in total debt, while ACO model entities are projected to contribute $40–$45 million to FY26 Adjusted EBITDA.